Clinical Trials
Closed
Phase
Accrual
3%
SWOG Clinical Trial Number
S9903
A Phase II Pilot Study of Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
Research Committee(s)
Brain Cancer
Melanoma
Activated
07-15-1999
Closed
06-15-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9812
Pilot Study of l-Selenomethionine in Prostate Cancer Patients Scheduled to Undergo Radical Prostatectomy
Activated
06-15-1999
Closed
06-01-2001
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
S9804
Evaluation of Vinorelbine Tartrate (Navelbine®) in Patients with Disseminated Malignant Melanoma and at Least One Prior Systemic Therapy, Phase II.
Research Committee(s)
Melanoma
Activated
05-15-1999
Closed
08-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9911
A Phase II Pilot Trial of CHOP Followed By Iodine-131-Labeled Monoclonal Anti-B1 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin’s Lymphomas
Research Committee(s)
Lymphoma
Activated
05-15-1999
Closed
06-01-2000
Closed
Phase
Accrual
13%
Published
SWOG Clinical Trial Number
S9809
The Effect of Fluoroquinolones on the Disease-Free Interval in Patients with Stage Ta Transitional Cell Carcinoma of the Bladder, Phase III
Research Committee(s)
Genitourinary Cancer
Activated
04-15-1999
Closed
07-01-2001
Closed
Phase
SWOG Clinical Trial Number
S9910
Leukemia Centralized Reference Laboratories and Tissue Repositories, Ancillary
Research Committee(s)
Leukemia
Activated
04-15-1999
Closed
01-01-2012
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9810
A Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma
Research Committee(s)
Sarcoma
Activated
02-15-1999
Closed
08-15-2000
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
S9811
Phase II Study of Hydroxyurea for Unresectable Meningioma
Activated
11-15-1998
Closed
06-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9806
Randomized Phase II Trial of Carboplatin/Gemcitabine Followed by Paclitaxel or Cisplatin/Vinorelbine Followed by Docetaxel in Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
11-01-1998
Closed
11-15-1999
Closed
Phase
Accrual
7%
SWOG Clinical Trial Number
S9716
A Phase II Trial of Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma)
Research Committee(s)
Melanoma
Activated
10-15-1998
Closed
08-15-2000
Closed
Phase
SWOG Clinical Trial Number
S9807
Repository for Paraffin Embedded Tissues from Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Research Committee(s)
Head and Neck Cancer
Activated
09-01-1998
Closed
02-15-2004
Closed
Phase
Accrual
18%
SWOG Clinical Trial Number
S9805
Phase II Study of Tandem High Dose Melphalan Supported, by Peripheral Blood Stem Cell Support in Waldenstrom’s Macroglobulinemia (WM).
Activated
09-01-1998
Closed
05-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9717
Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer, Phase II.
Research Committee(s)
Gynecologic Cancer
Activated
08-15-1998
Closed
08-15-2000
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
S9803
The Evaluation of Gemcitabine (Gemzar®) in Resistant and Relapsing Multiple Myeloma, Phase II
Activated
08-15-1998
Closed
12-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9832
Enhancing Well-Being During Breast Cancer Recurrence
Research Committee(s)
Breast Cancer
Activated
07-15-1998
Closed
11-15-2002
Closed
Phase
Accrual
18%
SWOG Clinical Trial Number
S9624
Evaluation of Ifosfamide/Mesna for Aggressive Meningeal Tumors (Malignant Meningioma, Hemangiopericytoma and Primary Nervous System Sarcoma), Phase II Study.
Research Committee(s)
Brain Cancer
Activated
07-01-1998
Closed
10-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9718
A Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9713
A Phase II Trial of Cisplatin/Etoposide and Concurrent, Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation For Limited Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
08-01-1999
Open
Phase
SWOG Clinical Trial Number
S9808
Long Term Follow-Up Protocol: An Administrative Tool.
Research Committee(s)
Other
Activated
06-15-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9802
A Phase II Trial of Gemcitabine in Advanced Soft Tissue Sarcomas
Activated
05-01-1998
Closed
03-15-1999